CompletedNCT06531876

Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

Studying Narcolepsy

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Beacon Biosignals
Principal Investigator: Dennis Hwang, MD
Kaiser Permanente
Intervention: Dreem 3S recording(device)
Enrollment: 78 enrolled
Eligibility: 18 years · All sexes
Timeline: 2024 – 2026

Study locations (4)

Kaiser Permanente Fontana Medical Center, Fontana, California, United States
Stanford University, Redwood City, California, United States
Sleep Insights Medical Associates PLLC, Rochester, New York, United States
Intrepid Research, Cincinnati, Ohio, United States

Collaborators

Kaiser Permanente · Stanford University · Intrepid Research · Sleep Insights · Sleep Management Institute

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06531876 on ClinicalTrials.gov

Other trials for Narcolepsy

Additional recruiting or active studies for the same condition.

See all trials for Narcolepsy →

← Back to all trials